22840-5707 : Blueberry .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution


NDC: 22840-5707
Labeler: Greer Laboratories, Inc.
Product Type: Non-standardized Allergenic
Drug Name: Blueberry
Dosage Form: Intradermal; Percutaneous; Subcutaneous Solution
Application #: BLA101833
Rev. Date: 


NDC Package Codes:

  • 22840-5707-2: 10 ML IN 1 VIAL, MULTI‑DOSE (22840‑5707‑2)
  • 22840-5707-5: 5 ML IN 1 BOTTLE, DROPPER (22840‑5707‑5)

Active Ingredients:

  • Velvetleaf Huckleberry

Dosage Strength:

  • .05 g/mL

Pharmaceutical Classes:

  • Allergens [CS]
  • Cell-mediated Immunity [PE]
  • Dietary Proteins [CS]
  • Fruit Proteins [EXT]
  • Increased Histamine Release [PE]
  • Non-Standardized Food Allergenic Extract [EPC]
  • Non-Standardized Plant Allergenic Extract [EPC]
  • Plant Proteins [CS]

Related Products:

Based on records with the same trade name.
  • 36987-1302 Blueberry .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1303 Blueberry .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1304 Blueberry .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 36987-1305 Blueberry .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
  • 49288-0055 Blueberry .05 g/ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
  • 54575-354 Blueberry 1 g/20ml Percutaneous; Subcutaneous Injection, Solution by Allergy Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 22840-5707 QR Code

< Prev: 22840-5706Next: 22840-5708 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.